CDKN2A and breast carcinoma: A case–control study found evidence for an independent association of PC risk with PGVs in six genes: ATM, BRCA1, BRCA2, CDKN2A, MLH1, and TP5316, five of which (excluding CDKN2A) have a clear link to breast cancer risk17–20.